UTI AMC Schedules Analyst/Investor Meeting with Shanghvi Family Office on May 19, 2026
UTI Asset Management Company Limited has disclosed a scheduled in-person analyst and institutional investor meeting with Shanghvi Family Office on May 19, 2026, at 1600 hrs IST at its Corporate Office in BKC, Mumbai. Filed under reference number UTI/AMC/CS/SE/2026-27/0662 on May 11, 2026, the meeting will be conducted on a one-on-one basis with no Unpublished Price Sensitive Information to be shared.

*this image is generated using AI for illustrative purposes only.
UTI AMC has informed the stock exchanges of a scheduled analyst and institutional investor meeting with its senior management, pursuant to Regulation 30 read with Schedule III Part A Para A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, along with relevant SEBI Circulars. The intimation, bearing reference number UTI/AMC/CS/SE/2026-27/0662, was filed on May 11, 2026.
Meeting Details
The following table outlines the key details of the scheduled meeting:
| Parameter: | Details |
|---|---|
| Date & Time: | 19th May, 2026 at 1600 hrs IST |
| Participant: | Shanghvi Family Office |
| Mode of Meeting: | In person |
| Venue: | Corporate Office, BKC, Mumbai |
Key Notes
The company has highlighted the following conditions applicable to the meeting:
- The date of the meeting is subject to change.
- No Unpublished Price Sensitive Information (UPSI) will be shared at the meeting.
- The meeting will be conducted on a one-on-one basis.
The intimation was signed by Arvind Patkar, Company Secretary and Compliance Officer (Membership No.: ACS 21577), on behalf of UTI Asset Management Company Limited.
Historical Stock Returns for UTI AMC
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.22% | +1.59% | +0.15% | -17.11% | -7.40% | +42.29% |
What strategic investment or partnership opportunities might the Shanghvi Family Office be exploring with UTI AMC that could signal a shift in the company's ownership structure?
How might increased interest from prominent family offices like Shanghvi's influence UTI AMC's AUM growth trajectory and product offerings in the near term?
Could this one-on-one meeting with the Shanghvi Family Office be a precursor to a significant block deal or stake acquisition in UTI AMC, and how would that impact its stock valuation?


































